Medicinal Cannabis Matters: Friday Roundup - 12 December 2025

Long-Term Endometriosis Study Shows Sustained Symptom Relief with Medicinal Cannabis

A new study has offered encouraging news for people living with endometriosis, a condition often noticeable by severe pelvic pain, fatigue, disrupted sleep and reduced daily functioning. According to findings reported by the Obstetrics & Gynecology Journal, patients using prescribed medicinal cannabis experienced sustained improvements across pain levels, mood, sleep and overall comfort over time.

For many individuals, conventional treatments such as hormonal therapy or long-term painkillers provide inconsistent or incomplete relief. In this study, medicinal cannabis appeared to support broader wellbeing, helping patients better manage flare-ups, sleep more consistently and regain a sense of control over daily life. These outcomes reinforce what many Medicann patients know: that personalised cannabis-based treatment can offer a gentler, more holistic approach to ongoing symptom burden.

Study Links Medicinal Cannabis to Reduced Opioid Use

A report from Cannabis Health News highlighted new research showing a significant reduction in prescription opioid use among patients receiving medicinal cannabis as part of their treatment plan.

The findings reflect one of the most important conversations in pain care today. Patients who rely on strong opioids often face challenges such as cognitive fog, sedation, dependency concerns and reduced day-to-day functionality. In contrast, many who transition to medicinal cannabis report clearer focus, fewer side effects and more sustainable symptom control.

At Medicann, we regularly hear from patients who have successfully reduced and discontinued long-term painkillers after starting treatment. While these decisions are always made under medical supervision, this growing body of evidence supports what clinicians are witnessing in practice: medicinal cannabis can offer an effective alternative that supports both physical functionality and quality of life.

Cannabis Oil and Advanced Liver Cancer

In a set of case reports, researchers documented tumour regression in several patients with advanced liver cancer who were using cannabis oil alongside other treatments.

Although early and based on individual cases rather than large clinical trials, these findings add to a growing global interest in how cannabinoids may interact with tumour activity, inflammation and cancer-related symptoms. It is essential to emphasise that cannabis oil is not a replacement for oncology care, but these early reports are helping researchers better understand the role cannabinoids may one day play in complex cancer symptom management and supplementary support.

For now, these case reports highlight the potential range of therapeutic benefit extending far beyond pain and anxiety management and into emerging territories of medical science.

If you are considering whether medicinal cannabis could support your health or help you manage ongoing symptoms, the first step is to use our online eligibility checker. It is quick, confidential and available to patients across England, Wales, Scotland, Northern Ireland and the Channel Islands.

Whether you’re dealing with chronic pain, women’s health conditions, long-term illness or simply want to understand your options, taking that first step may help you move towards safer, more personalised care.

Disclaimer: This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.